Log in

Relevant bibliographies by topics / 6-Thioguanin

Contents

Journal articles
Dissertations / Theses
Book chapters
Conference papers

Academic literature on the topic '6-Thioguanin'

Author: Grafiati

Published: 4 June 2021

Last updated: 18 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic '6-Thioguanin.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "6-Thioguanin"

1

Klugmann, T., and B. Bokemeyer. "Langzeit-Verträglichkeit der 6-Thioguanin- Therapie bei CED-Patienten in der gastroenterologischen Fachpraxis." Verdauungskrankheiten 23, no. 07 (2005): 181–85. http://dx.doi.org/10.5414/vdp23181.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Haas, R., A. Mundinger, T. Bohn, K. Schaz, and W. Hunstein. "Therapiemöglichkeiten beim Hypereosinophilie-Syndrom mit Endomyocarditis fibroplastica Löffler: Wirksamkeit von Cytarabin und 6-Thioguanin." DMW - Deutsche Medizinische Wochenschrift 110, no. 41 (2008): 1573–76. http://dx.doi.org/10.1055/s-2008-1069049.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Abrahamsson, Jonas, Erik Forestier, Jesper Heldrup, et al. "Response-Guided Induction Therapy in Pediatric Acute Myeloid Leukemia With Excellent Remission Rate." Journal of Clinical Oncology 29, no. 3 (2011): 310–15. http://dx.doi.org/10.1200/jco.2010.30.6829.

Full text

Abstract:

Purpose To evaluate the early treatment response in children with acute myeloid leukemia (AML) using a response-guided induction strategy that includes idarubicin in the first course. Patients and Methods All Nordic children with AML younger than 15 years (n = 151) were treated on the Nordic Society for Pediatric Hematology and Oncology (NOPHO) AML 2004 protocol. After the first course of idarubicin, cytarabine, etoposide, and 6-thioguanin, patients with good response were allowed hematologic recovery before the second course, whereas patients with a poor (≥ 15% blasts) or intermediate (5% to

APA, Harvard, Vancouver, ISO, and other styles

4

Herrlinger, Klaus R., Matthias Schwab, Klaus Fellermann, and Eduard F. Stange. "6-thioguanine-buried alive?" Gastroenterology 126, no. 3 (2004): 940–41. http://dx.doi.org/10.1053/j.gastro.2004.01.044.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Feistner, Gottfried, and Carle M. Staub. "6-Thioguanine fromErwinia amylovora." Current Microbiology 13, no. 2 (1986): 95–101. http://dx.doi.org/10.1007/bf01568289.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Josting, Andreas, Sabine Wiedenmann, Jeremy Franklin, et al. "Secondary Myeloid Leukemia and Myelodysplastic Syndromes in Patients Treated for Hodgkin’s Disease: A Report From the German Hodgkin’s Lymphoma Study Group." Journal of Clinical Oncology 21, no. 18 (2003): 3440–46. http://dx.doi.org/10.1200/jco.2003.07.160.

Full text

Abstract:

Purpose: To assess the incidence and outcome of secondary acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) in patients with Hodgkin’s disease (HD). Patients and Methods: Between 1981 and 1998, the GHSG conducted three trial generations for early, intermediate, and advanced HD involving a total of 5,411 patients (called HD1 through HD9). Results: A total of 46 patients with secondary AML/MDS were identified. The median age at diagnosis of leukemia was 47 years (range, 22 to 79 years). Primary therapy was as follows: radiotherapy alone (n = 4); doxorubicin, bleomycin, vinblastine,

APA, Harvard, Vancouver, ISO, and other styles

7

Kraske, P. J., and Brajter-Toth. "Electrochemical oxidation of 6-thioguanine." Journal of Electroanalytical Chemistry and Interfacial Electrochemistry 207, no. 1-2 (1986): 101–16. http://dx.doi.org/10.1016/0022-0728(86)87065-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Sherer, Daniel W., and Mark G. Lebwohl. "6-Thioguanine in the Treatment of Psoriasis: A Case Report and Literature Review." Journal of Cutaneous Medicine and Surgery 6, no. 6 (2002): 546–50. http://dx.doi.org/10.1177/120347540200600605.

Full text

Abstract:

Background: 6-Thioguanine is a purine analog primarily indicated for acute myelogenous leukemia. Its use in psoriasis was first investigated in the 1950s and current interest in serious treatments for psoriasis, such as cyclosporine, has renewed interest in this medication. Newer therapies, such as PUVA and retinoids, have side effects as do some older treatments, such as methotrexate, which fell into favor at the same time 6-thioguanine was being investigated. Reexamining older treatments can open up new therapeutic options in difficult cases. Objective: The goal of this article is to provide

APA, Harvard, Vancouver, ISO, and other styles

9

Wensing, A., M. Gernold, S. Jock, et al. "6-THIOGUANINE BIOSYNTHESIS IN ERWINIA SPECIES." Acta Horticulturae, no. 1056 (October 2014): 165–67. http://dx.doi.org/10.17660/actahortic.2014.1056.25.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Siouri, Faady M., Samuel Boldissar, Jacob A. Berenbeim, and Mattanjah S. de Vries. "Excited State Dynamics of 6-Thioguanine." Journal of Physical Chemistry A 121, no. 28 (2017): 5257–66. http://dx.doi.org/10.1021/acs.jpca.7b03036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "6-Thioguanin"

1

Tafazzoli-Lari, Julia Frederike [Verfasser]. "Zusammenhang zwischen der klinischen Symptomatik der Multiplen Sklerose und ausgewählten Parametern des Thiopurinstoffwechsels (Thiopurin-S-Methyltransferase-Aktivität, 6-Thioguanin, 6 Methyl-Thioguanin und 6-Methyl-Mercaptopurin) / Julia Frederike Tafazzoli-Lari." Lübeck : Zentrale Hochschulbibliothek Lübeck, 2011. http://d-nb.info/1011801132/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Samuels, C. S. "An evaluation of 6-thioguanine derivatives as potential anti-cancer agents." Pretoria : [s.n.], 2008. http://upetd.up.ac.za/thesis/available/etd-11262009-174642/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Wolfreys, Alison Mandy. "Molecular mutation spectra of 6-thioguanine resistant human T-lymphocyte and UV-irradiated lymphoblastoid mutants." Thesis, University of Sussex, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.266549.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Fotoohi, Alan Kambiz. "Pharmacological and molecular investigations on the mechanisms underlying resistance of human leukaemia cells to the antimetabolites methotrexate, 6-mercaptopurine and 6-thioguanine /." Stockholm, 2007. http://diss.kib.ki.se/2007/978-91-7357-087-9/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Humpolíková, Jiřina. "Elektrochemické stanovení 6-thioguaninu na borem dopované diamantové filmové elektrodě." Master's thesis, 2013. http://www.nusl.cz/ntk/nusl-322169.

Full text

Abstract:

This master's thesis is focused on the determination of 6-thioguanine (6-T) by DC voltammetry (DCV), differential pulse voltammetry (DPV) and flow injection analysis with electrochemical detection (FIA-ED) on a boron doped diamond electrode (BDDFE). The optimum conditions for determination of 6-T were found and under these conditions, concentration dependences were measured and the limits of quantification (LOQ) were calculated for each method. Medium of 60% methanol and phosphate buffer (PB) pH 2,0 was chosen as optimum for DCV and DPV determination of 6-T at BDDFE. For both DCV and DPV, the

APA, Harvard, Vancouver, ISO, and other styles

6

Kotalczyk-Zepke, Adam [Verfasser]. "Neue HPLC-Methode zur parallelen Bestimmung und Quantifizierung der Nukleotide von 6-Thioguanin, 6-Mercaptopurin und ihrer Metabolite : Evaluation der Methode durch Untersuchung der Metabolite und Stoffwechselwege in vitro und bei Patienten / vorgelegt von Adam Kotalczyk-Zepke." 2006. http://d-nb.info/981724841/34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Samuels, Caroline Selma. "An evaluation of 6-thioguanine derivatives as potential anti-cancer agents." Diss., 2009. http://hdl.handle.net/2263/29834.

Full text

Abstract:

During neoplastic development cellular requirements for the micronutrients and macronutrients increase dramatically for the primary metabolites, sugar and amino-acids. This concept of increased cellular needs lead to the development of antimetabolites as anticancer agents. Antimetabolites, are structurally similar to that of physiological metabolites, but have the ability to interfere with normal metabolic functioning of the cell that eventually leads to cell death. One such agent used in chemotherapy is 6-thioguanine. Another group of agents that also only recently showed potential for the us

APA, Harvard, Vancouver, ISO, and other styles

8

Hwang, In Young. "Synthesis and evaluation of S-conjugates as kidney-selective prodrugs of 6-mercaptopurine and 6-thioguanine." 1992. http://catalog.hathitrust.org/api/volumes/oclc/28706593.html.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Lin, Hsin-Cheng, and 林昕成. "Inhibition studies of human ubiquitin specific protease 2 and 21 by disulfiram and 6-thioguanine." Thesis, 2019. http://ndltd.ncl.edu.tw/handle/4yy872.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Estevinho, Maria Manuela Fernandes. "A systematic review and meta-analysis on 6-thioguanine nucleotides levels and clinical remission in inflammatory bowel disease." Dissertação, 2018. https://hdl.handle.net/10216/112120.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "6-Thioguanin"

1

Herrlinger, K. "Therapiealternativen in der Immunsuppression — Mycophenolat-Mofetil und 6-Thioguanin." In Chronisch entzündliche Darmerkrankungen. Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-19025-4_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Lucano, A., C. Crifò, and C. Salerno. "6-Thioguanine Metabolism in Human Erythrocytes." In Advances in Experimental Medicine and Biology. Springer US, 1991. http://dx.doi.org/10.1007/978-1-4899-2638-8_20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Rubin, Yu V., and V. S. Leontiev. "Spectroscopic Study of DNA with Built-in 6 Thioguanine." In Spectroscopy of Biological Molecules. Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0371-8_268.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Kröplin, T., N. Weyer, and H. Iven. "Determination of Thiopurine Methyltransferase Activity in Erythrocytes Using 6-Thioguanine as the Substrate." In Advances in Experimental Medicine and Biology. Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5381-6_142.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Dervieux, Thierry, and Roselyne Boulieu. "A HPLC Method for the Monitoring of Human Red Cell 6-Thioguanine and Methyl 6-Mercaptopurine in a Single Run." In Advances in Experimental Medicine and Biology. Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5381-6_140.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Nowrousian, M. R., R. Pfeiffer, U. W. Schaefer, et al. "Remission Induction with Cytarabine and Daunorubicin With or Without 6-Thioguanine in Adult Patients With Acute Myelocytic Leukemia." In Acute Leukemias. Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71213-5_57.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Pieters, R., D. R. Huismans, A. H. Loonen, K. Hählen, and A. J. P. Veerman. "Vitamin A Does Not Enhance the Antileukemic Effect of Vincristine, Daunorubicin, and 6-Thioguanine in Acute Lymphoblastic Leukemia Cells." In Haematology and Blood Transfusion / Hämatologie und Bluttransfusion. Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-78350-0_41.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Trueworthy, R. C., R. A. DeAbreu, L. H. J. Lambooy, J. P. M. Bökkerink, and E. H. Stet. "Action and Sequence Dependent Interaction of Acivicin and 6-Thioguanine in Human Derived Malignant T-All and Calla+ Cell Lines." In Advances in Experimental Medicine and Biology. Springer US, 1991. http://dx.doi.org/10.1007/978-1-4899-2638-8_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Hassan, Iffat, and Peerzada Ahmad. "6-Thioguanine in Psoriasis." In A Comprehensive Textbook of Psoriasis. Jaypee Brothers Medical Publishers (P) Ltd., 2016. http://dx.doi.org/10.5005/jp/books/12839_30.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

"Thioguanine (2-amino-1,7-dihydro-6H-purine-6-thione)." In Encyclopedia of Genetics, Genomics, Proteomics and Informatics. Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-6754-9_16927.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "6-Thioguanin"

1

Rubin, Yuri V. "Physical properties of anticancer drug 6-thioguanine." In SPIE Proceedings, edited by Galyna O. Puchkovska, Tatiana A. Gavrilko, and Olexandr I. Lizengevich. SPIE, 2004. http://dx.doi.org/10.1117/12.570014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Khare, Kirtesh Pratap, Rachana Kathal, Neelima Shukla, Reena Srivastava, and Anurag Srivastava. "6 thioguanine sensing using poly pyrrole: DFT study." In ADVANCED MATERIALS AND RADIATION PHYSICS (AMRP-2020): 5th National e-Conference on Advanced Materials and Radiation Physics. AIP Publishing, 2021. http://dx.doi.org/10.1063/5.0052388.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Yalchin, Mehmet, Lukasz Kamieniarz, Rigers Cama, Samuel Tribich, and Andreas Koutsoumpas. "PWE-069 Measuring thioguanine nucleotide (6-TGN) levels and clinical response in IBD." In British Society of Gastroenterology, Annual General Meeting, 4–7 June 2018, Abstracts. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2018. http://dx.doi.org/10.1136/gutjnl-2018-bsgabstracts.201.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Khare, Kirtesh Pratap, Rachana Kathal, Neelima Shukla, Reena Srivastava, and Anurag Srivastava. "Sensing behavior of poly-9 vinyl carbazole for 6-Thioguanine anti-cancer drug: A DFT study." In NATIONAL CONFERENCE ON PHYSICS AND CHEMISTRY OF MATERIALS: NCPCM2020. AIP Publishing, 2021. http://dx.doi.org/10.1063/5.0060836.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Tedeschi, Philip M., Yamini K. Kathari, Iqra Farooqi, and Joseph R. Bertino. "Abstract 843: Methylthioadenosine phosphorylase (MTAP)-deficient T-cell ALL xenografts are sensitive to pralatrexate and 6-thioguanine alone and in combination." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-843.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Bertino, Joseph R., Nadine Johnson-Farley, Raymond P. Perez, Adam Lubin, and Martin Lubin. "Abstract 5393: Regression of a human T-cell leukemia lacking the methylthioadenosine phosphorylase (MTAP) gene without toxicity of 6-thioguanine (6TG) by pretreatment with methylthioadenosine (MTA)." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-5393.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!